title: Renal dysfunction as an independent predictor of total mortality after acute coronary syndrome: the Thai ACS Registry.
abstract: BACKGROUND
  Renal insufficiency in the acute coronary syndrome (ACS) is associated with poor cardiac outcome. In Asian populations, there are no data available for these associations.
  
  
  METHODS
  Data was from the Thai ACS registry, only a new case of ACS. Clinical characteristics, treatment strategies, in-hospital mortality and 1-year mortality were compared for patients with normal or mild renal dysfunction (estimated glomerular filtration rate [eGFR]> 60 ml/minute/1.73 m2, n = 809 [44.5%]), moderate renal dysfunction (eGFR 30-60 ml/minute/1.73 m2, n = 706 [38.9%]), and severe renal dysfunction (eGFR < 30 ml/minute/1.73 m2, n = 301 [16.6%]).
  
  
  RESULTS
  Of the 1,816patients with mean follow-up 10.8 months, the mean age was 65 years, and 59.2 percent of the groups were male. Patients with severe renal dysfunction were significantly older, less likely to be male (45.2%, p < 0.001) and had a greater prevalence of diabetes (63.1%, p < 0.001) and hypertension (85.4%, p < 0.001). In-hospital and 1-year mortality were 13.5% and 22.5% respectively. According to discharge diagnosis, unadjusted hazard ratios for overall in-hospital mortality was statistically significant only in ST elevation MI subgroup, hazard ratio was 2.73 (95% CI, 1.72 to 4.34) and 6.27 (95% CI, 3.78 to 10.4) for moderate and severe renal dysfunction group, respectively. The risk of death for all types of ACS at 1-year follow up increased when eGFR decreased below 60 ml/minute/1.73 m2, the adjusted hazard ratio was 1.66 (95% CI,1.22 to 2.23) and 1.91 (95% CI, 1.34 to 2.72) for moderate and severe renal dysfunction group, respectively.
  
  
  CONCLUSIONS
  From Thai ACS registry, renal dysfunction at presentation is an independent predictor for the overall 1-year mortality and appeared to associate with an increase in hospital mortality in the subsets with STEMI
authors.affiliation: Division of Cardiology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
authors.forename: Khorawit
authors.initials: K
authors.lastname: Sooklim
authors.forename: Suphot
authors.initials: S
authors.lastname: Srimahachota
authors.forename: Smonporn
authors.initials: S
authors.lastname: Boonyaratavej
authors.forename: Rungsrit
authors.initials: R
authors.lastname: Kanjanavanit
authors.forename: Napa
authors.initials: N
authors.lastname: Siriviwattanakul
authors.forename: Chumpol
authors.initials: C
authors.lastname: Piamsomboon
authors.forename: Rangson
authors.initials: R
authors.lastname: Ratanaprakarn
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications / Q000453:epidemiology / Q000401:mortality*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003404:Creatinine / Q000097:blood; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D017052:Hospital Mortality / Q000639:trends*; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology / Q000401:mortality* / Q000503:physiopathology; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011379:Prognosis; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D013785:Thailand / Q000453:epidemiology
chemical_list: D005343:Fibrinolytic Agents; D003404:Creatinine